Angiogenesis is crucial to restore microvascular perfusion in the jeopardized myocardium in
the weeks following reperfused ST-segment elevation myocardial infarction (STEMI).(VEGF) …

Introduction and objectives Angiogenesis helps to reestablish microcirculation after
myocardial infarction (MI). In this study, we aimed to further understand the role of the …

Background Vascular endothelial growth factor-A (VEGF-A) promotes neovascularization
and is attracting considerable attention as a remarkable risk factor in patients after acute …

The current study is to determine the regulatory role of VEGF-A in cardiac angiogenesis
following myocardial infarction (MI). Cardiac angiogenic response and temporal/spatial …

Background Microvascular obstruction (MVO) is associated with poor outcome after ST-
segment elevation myocardial infarction (STEMI). Vascular endothelial growth factor-A …

Objective—The endogenous role of the VEGF family member vascular endothelial growth
factor-B (VEGF-B) in pathological angiogenesis remains unclear. Methods and Results—We …

Vascular endothelial growth factor-B (VEGF-B, see Olofsson et al1) is one of 5 mammalian
VEGF family members, the others being VEGF-A, VEGF-C, VEGF-D, and placental growth …

Background—New revascularization therapies are urgently needed for patients with severe
coronary heart disease who lack conventional treatment options. Methods and Results—We …

BACKGROUND: Clinical trials of vascular endothelial growth factor (VEGF) gene therapy
have proven that VEGF has beneficial effects on the ischemic heart disease; however, the …

Purpose. The aim of this study was to determine whether the combination of 2 angiogenic
growth factor, vascular endothelial growth factor 165 (VEGF165) and angiopoietin-1 (Ang1) …